TPRG1
geneOn this page
Also known as FLJ41238FLJ43694
Summary
TPRG1 (tumor protein p63 regulated 1, HGNC:24759) is a protein-coding gene on chromosome 3q28, encoding Tumor protein p63-regulated gene 1 protein (Q6ZUI0).
Predicted to be active in cytoplasm.
Source: NCBI Gene 285386 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 43 total
- MANE Select transcript:
NM_198485
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24759 |
| Approved symbol | TPRG1 |
| Name | tumor protein p63 regulated 1 |
| Location | 3q28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ41238, FLJ43694 |
| Ensembl gene | ENSG00000188001 |
| Ensembl biotype | protein_coding |
| Entrez | 285386 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 24 protein_coding, 10 protein_coding_CDS_not_defined
ENST00000345063, ENST00000412373, ENST00000425670, ENST00000433971, ENST00000456832, ENST00000460613, ENST00000464152, ENST00000473790, ENST00000479720, ENST00000481307, ENST00000485836, ENST00000488841, ENST00000493725, ENST00000496671, ENST00000497628, ENST00000867713, ENST00000867714, ENST00000867715, ENST00000867716, ENST00000867717, ENST00000867718, ENST00000867719, ENST00000867720, ENST00000867721, ENST00000867722, ENST00000867723, ENST00000867724, ENST00000949786, ENST00000949787, ENST00000949788, ENST00000949789, ENST00000949790, ENST00000949791, ENST00000949792
RefSeq mRNA: 1 — MANE Select: NM_198485
NM_198485
CCDS: CCDS3292
Canonical transcript exons
ENST00000345063 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001372486 | 189238733 | 189238909 |
| ENSE00001389174 | 189320626 | 189325304 |
| ENSE00001427712 | 189171971 | 189172131 |
| ENSE00003593052 | 189310386 | 189310539 |
| ENSE00003630174 | 189207376 | 189207594 |
| ENSE00003789158 | 189215292 | 189215383 |
Expression profiles
Bgee: expression breadth ubiquitous, 208 present calls, max score 98.48.
FANTOM5 (CAGE): breadth broad, TPM avg 3.2370 / max 228.5142, expressed in 487 samples.
FANTOM5 promoters (20 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40509 | 0.6606 | 38 |
| 40513 | 0.5393 | 83 |
| 40498 | 0.2703 | 61 |
| 40481 | 0.2516 | 131 |
| 40482 | 0.1733 | 96 |
| 40511 | 0.1667 | 51 |
| 40500 | 0.1561 | 29 |
| 40501 | 0.1442 | 34 |
| 40497 | 0.1394 | 55 |
| 40480 | 0.1030 | 54 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 98.48 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 97.83 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 96.59 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 95.19 | gold quality |
| oral cavity | UBERON:0000167 | 94.93 | gold quality |
| upper leg skin | UBERON:0004262 | 94.73 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.97 | gold quality |
| skin of leg | UBERON:0001511 | 93.33 | gold quality |
| penis | UBERON:0000989 | 92.37 | gold quality |
| zone of skin | UBERON:0000014 | 92.27 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.20 | gold quality |
| upper arm skin | UBERON:0004263 | 91.85 | gold quality |
| mammalian vulva | UBERON:0000997 | 91.52 | gold quality |
| vagina | UBERON:0000996 | 91.08 | gold quality |
| amniotic fluid | UBERON:0000173 | 90.88 | gold quality |
| ectocervix | UBERON:0012249 | 89.71 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 89.09 | gold quality |
| right lobe of liver | UBERON:0001114 | 88.68 | gold quality |
| gingiva | UBERON:0001828 | 88.39 | gold quality |
| buccal mucosa cell | CL:0002336 | 88.32 | gold quality |
| tendon | UBERON:0000043 | 86.89 | gold quality |
| right uterine tube | UBERON:0001302 | 86.85 | gold quality |
| uterine cervix | UBERON:0000002 | 86.80 | gold quality |
| gingival epithelium | UBERON:0001949 | 86.56 | gold quality |
| skin of hip | UBERON:0001554 | 86.10 | gold quality |
| adipose tissue | UBERON:0001013 | 85.14 | gold quality |
| body of tongue | UBERON:0011876 | 84.93 | gold quality |
| granulocyte | CL:0000094 | 84.81 | gold quality |
| endocervix | UBERON:0000458 | 84.60 | gold quality |
| right lung | UBERON:0002167 | 84.12 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.22 |
| E-MTAB-7249 | no | 84.33 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP63
miRNA regulators (miRDB)
99 targeting TPRG1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
Literature-anchored findings (GeneRIF, showing 1)
- Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-small ka, CyrillicB/cyclooxygenase-2/prostaglandin E2 axis. (PMID:34998360)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tprg1 | ENSDARG00000056026 |
| mus_musculus | Tprg1 | ENSMUSG00000048399 |
| rattus_norvegicus | Tprg1 | ENSRNOG00000063970 |
Paralogs (1): TPRG1L (ENSG00000158109)
Protein
Protein identifiers
Tumor protein p63-regulated gene 1 protein — Q6ZUI0 (reviewed: Q6ZUI0)
Alternative names: Protein FAM79B
All UniProt accessions (4): Q6ZUI0, C9IYC1, C9JDW1, H7C1G4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
Tissue specificity. Expressed in the epidermal layer of the skin.
Similarity. Belongs to the TPRG1 family.
RefSeq proteins (1): NP_940887* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022158 | Inositol_phosphatase | Domain |
| IPR034753 | hSac2 | Domain |
| IPR040242 | TPRG1-like | Family |
Pfam: PF12456
UniProt features (4 total): chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZUI0-F1 | 73.90 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
LEE_SP4_THYMOCYTE, TGACATY_UNKNOWN, MAF_Q6, CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP, CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN, VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP, LEE_RECENT_THYMIC_EMIGRANT, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ARID5B_TARGET_GENES, GREB1_TARGET_GENES, LHX9_TARGET_GENES, NFKBIA_TARGET_GENES, PBXIP1_TARGET_GENES, ZNF92_TARGET_GENES, MIR3658
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
560 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TPRG1 | TP63 | Q9H3D4 | 490 |
| TPRG1 | CFAP95 | Q5VTT2 | 403 |
| TPRG1 | ABHD14A | Q9BUJ0 | 371 |
| TPRG1 | SACK1C | Q9BQN1 | 371 |
| TPRG1 | SUSD1 | Q6UWL2 | 366 |
| TPRG1 | S100PBP | Q96BU1 | 354 |
| TPRG1 | WDR6 | Q9NNW5 | 348 |
| TPRG1 | CBFA2T3 | O75081 | 347 |
| TPRG1 | EVA1C | P58658 | 347 |
| TPRG1 | CCDC18 | Q5T9S5 | 344 |
| TPRG1 | FOXRED2 | Q8IWF2 | 315 |
| TPRG1 | C1orf162 | Q8NEQ5 | 312 |
| TPRG1 | TULP2 | O00295 | 309 |
| TPRG1 | PIP4K2A | P48426 | 306 |
| TPRG1 | MEF2B | Q02080 | 296 |
IntAct
58 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TPRG1 | HSD17B13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | APOC4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | RETREG3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFSD14B | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOC4 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | SLC35C2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOC1 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDD2 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | SCN3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | HSD17B11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | REEP4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EBAG9 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | CGRRF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | TMEM120A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC10A6 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AQP6 | TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TPRG1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| STX17 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| OR2A4 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCR1 | UBA6 | psi-mi:“MI:0914”(association) | 0.350 |
| TPRG1 | RHBDD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (23): TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TPRG1 (Two-hybrid), TMEM120A (Two-hybrid)
ESM2 similar proteins: A0A1B7XV12, A0A571BF63, A0A5F8MPE6, A0JMA8, A3KQ58, A6NEN9, A6QNM3, A8E7C5, A8PJX4, B0W730, O00443, O00522, O59800, P70371, Q08AE8, Q0VA04, Q0VA42, Q14D04, Q16YA8, Q32LJ3, Q3V2K1, Q4R707, Q52KF3, Q5F3E8, Q5PQS3, Q5RAY1, Q5UQM6, Q5XIR8, Q61QK6, Q63ZP1, Q6C4Q6, Q6DTM3, Q6ING4, Q6NSI8, Q6S5J6, Q6TNJ1, Q6ZUI0, Q7Z3E5, Q7ZXG4, Q86VD1
Diamond homologs: A8WCF8, Q32LJ4, Q5T0D9, Q6ZUI0, Q8CB49, Q9DBS2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4816 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:189207576:G:GT | donor_gain | 1.0000 |
| 3:189215384:G:GG | donor_gain | 1.0000 |
| 3:189238728:TATA:T | acceptor_loss | 1.0000 |
| 3:189238730:TAGGA:T | acceptor_loss | 1.0000 |
| 3:189238731:A:AG | acceptor_gain | 1.0000 |
| 3:189238731:AG:A | acceptor_gain | 1.0000 |
| 3:189238731:AGGAT:A | acceptor_loss | 1.0000 |
| 3:189238732:G:GC | acceptor_loss | 1.0000 |
| 3:189238732:G:GG | acceptor_gain | 1.0000 |
| 3:189238732:GG:G | acceptor_gain | 1.0000 |
| 3:189238732:GGATA:G | acceptor_gain | 1.0000 |
| 3:189238905:GACAA:G | donor_gain | 1.0000 |
| 3:189238909:AGT:A | donor_loss | 1.0000 |
| 3:189238910:G:GG | donor_gain | 1.0000 |
| 3:189238910:GTG:G | donor_loss | 1.0000 |
| 3:189238911:TGA:T | donor_loss | 1.0000 |
| 3:189238912:GAG:G | donor_loss | 1.0000 |
| 3:189277108:G:GT | donor_gain | 1.0000 |
| 3:189320622:TCAGT:T | acceptor_loss | 1.0000 |
| 3:189320624:A:AG | acceptor_gain | 1.0000 |
| 3:189320624:AGTT:A | acceptor_gain | 1.0000 |
| 3:189320625:G:GG | acceptor_gain | 1.0000 |
| 3:189320625:GT:G | acceptor_gain | 1.0000 |
| 3:189320625:GTT:G | acceptor_gain | 1.0000 |
| 3:189320625:GTTG:G | acceptor_gain | 1.0000 |
| 3:189320625:GTTGT:G | acceptor_gain | 1.0000 |
| 3:189123567:A:AG | acceptor_gain | 0.9900 |
| 3:189123568:A:G | acceptor_gain | 0.9900 |
| 3:189123570:A:AG | acceptor_gain | 0.9900 |
| 3:189123571:A:G | acceptor_gain | 0.9900 |
AlphaMissense
1796 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:189310450:T:A | W182R | 0.987 |
| 3:189310450:T:C | W182R | 0.987 |
| 3:189320815:T:C | F275L | 0.987 |
| 3:189320817:T:A | F275L | 0.987 |
| 3:189320817:T:G | F275L | 0.987 |
| 3:189238743:T:A | W105R | 0.979 |
| 3:189238743:T:C | W105R | 0.979 |
| 3:189238748:C:A | N106K | 0.978 |
| 3:189238748:C:G | N106K | 0.978 |
| 3:189207583:T:C | F67L | 0.977 |
| 3:189207585:T:A | F67L | 0.977 |
| 3:189207585:T:G | F67L | 0.977 |
| 3:189215311:C:A | A77D | 0.976 |
| 3:189310487:T:C | F194S | 0.973 |
| 3:189238759:A:T | E110V | 0.969 |
| 3:189238882:T:C | F151S | 0.969 |
| 3:189238789:T:C | L120P | 0.968 |
| 3:189310496:A:G | H197R | 0.967 |
| 3:189310497:T:A | H197Q | 0.967 |
| 3:189310497:T:G | H197Q | 0.967 |
| 3:189238747:A:T | N106I | 0.964 |
| 3:189238745:G:C | W105C | 0.963 |
| 3:189238745:G:T | W105C | 0.963 |
| 3:189238804:A:C | Y125S | 0.963 |
| 3:189320816:T:C | F275S | 0.963 |
| 3:189207593:G:C | R70P | 0.962 |
| 3:189238803:T:G | Y125D | 0.962 |
| 3:189310403:T:C | L166P | 0.959 |
| 3:189320788:T:G | Y266D | 0.959 |
| 3:189320800:C:A | R270S | 0.959 |
dbSNP variants (sampled 300 via entrez): RS1000003247 (3:189295775 T>C), RS1000008947 (3:189276681 A>G), RS1000009433 (3:189146984 C>T), RS1000056188 (3:189294570 A>T), RS1000059958 (3:189276970 A>C), RS1000066234 (3:189162762 T>TG), RS1000073274 (3:189297106 G>A), RS1000076468 (3:189078295 G>A), RS1000086935 (3:189150469 C>A,T), RS1000093997 (3:189162466 A>T), RS1000097212 (3:189229868 G>A,T), RS1000106698 (3:188997367 C>T), RS1000110405 (3:189123665 C>G), RS1000119717 (3:189271540 A>G), RS1000126407 (3:189064900 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002115_8 | Axial length | 3.000000e-07 |
| GCST003327_8 | Squamous cell carcinoma | 1.000000e-11 |
| GCST003479_2 | Hair color | 3.000000e-06 |
| GCST006409_20 | Allergic rhinitis | 2.000000e-13 |
| GCST009798_88 | Asthma | 5.000000e-11 |
| GCST010148_6 | Cutaneous squamous cell carcinoma | 6.000000e-15 |
| GCST012490_365 | Femur bone mineral density x serum urate levels interaction | 3.000000e-12 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005318 | axial length measurement |
| EFO:1001927 | cutaneous squamous cell carcinoma |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, increases expression | 3 |
| methyleugenol | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| 3,4-dichloroaniline | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| hydroquinone | increases expression | 1 |
| abrine | increases expression | 1 |
| bisphenol S | decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 finite cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B4GJ | WG4066 | Finite cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): allergic rhinitis, squamous cell carcinoma